← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Kurzius Lawrence Erik
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001352090
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 5
- Purchases · 24M
- 7
- Average purchase
- $392.9K
- Median purchase
- $213.0K
- Gross purchase value
- $2.8M
Companies: COOPER COMPANIES, INC. | Elanco Animal Health Inc
7 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-09-17 | COOPER COMPANIES, INC. | COO | Director | $549.3K | Open filing |
| 2026-09-15 | COOPER COMPANIES, INC. | COO | Director | $539.2K | Open filing |
| 2026-08-21 | Elanco Animal Health Inc | ELAN | Director | $936.0K | Open filing |
| 2025-12-17 | COOPER COMPANIES, INC. | COO | Director | $165.0K | Open filing |
| 2025-12-16 | Elanco Animal Health Inc | ELAN | Director | $213.0K | Open filing |
| 2025-09-29 | COOPER COMPANIES, INC. | COO | Director | $136.8K | Open filing |
| 2025-03-11 | Elanco Animal Health Inc | ELAN | Director | $211.0K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 7Developing | 100.0% (7/7) | 71.4% (5/7) | +1.4% | +1.0% | -3.0% |
| 20D | 6Developing | 85.7% (6/7) | 33.3% (2/6) | -2.0% | -1.4% | -7.7% |
| 60D | 4Small Sample | 100.0% (4/4) | 75.0% (3/4) | +11.9% | +9.4% | -12.8% |
| 120D | 4Small Sample | 100.0% (4/4) | 50.0% (2/4) | -0.6% | +8.0% | -28.7% |
Research patterns
- First purchase in 12M
- 0/5
- Large purchase ≥ $100k
- 7/7
- Cluster buying · 15D
- 6/7
- Buying the dip
- 4/7
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.